Works by Halbgebauer, Steffen


Results: 41
    1

    Diagnostic performance of plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non‐AD dementias: An international multi‐center study.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2025, v. 21, n. 6, p. 1, doi. 10.1002/alz.14573
    By:
    • Doecke, James D.;
    • Bellomo, Giovanni;
    • Vermunt, Lisa;
    • Alcolea, Daniel;
    • Halbgebauer, Steffen;
    • in 't Veld, Sjors;
    • Mattsson‐Carlgren, Niklas;
    • Veverova, Katerina;
    • Fowler, Christopher J.;
    • Boonkamp, Lynn;
    • Houtkamp, Isabel M.;
    • Koel‐Simmerlink, Marleen;
    • Verberk, Inge M. W.;
    • Gaetani, Lorenzo;
    • Toja, Andrea;
    • Wojdała, Anna Lidia;
    • Fortea, Juan;
    • Pijnenburg, Yolande;
    • Lemstra, Afina;
    • van der Flier, Wiesje
    Publication type:
    Article
    2

    Phosphorylated tau 181 and 217 are elevated in serum and muscle of patients with amyotrophic lateral sclerosis.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-57144-7
    By:
    • Abu-Rumeileh, Samir;
    • Scholle, Leila;
    • Mensch, Alexander;
    • Großkopf, Henning;
    • Ratti, Antonia;
    • Kölsch, Anna;
    • Stoltenburg-Didinger, Gisela;
    • Conrad, Julian;
    • De Gobbi, Anna;
    • Barba, Lorenzo;
    • Steinacker, Petra;
    • Klafki, Hans-Wolfgang;
    • Oeckl, Patrick;
    • Halbgebauer, Steffen;
    • Stapf, Caroline;
    • Posa, Andreas;
    • Kendzierski, Thomas;
    • Silani, Vincenzo;
    • Hausner, Lucrezia;
    • Ticozzi, Nicola
    Publication type:
    Article
    3

    Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-56293-z
    By:
    • Bolsewig, Katharina;
    • Willemse, Eline A. J.;
    • Sánchez-Juan, Pascual;
    • Rábano, Alberto;
    • Martínez, Minerva;
    • Doecke, James D.;
    • Bellomo, Giovanni;
    • Vermunt, Lisa;
    • Alcolea, Daniel;
    • Halbgebauer, Steffen;
    • in 't Veld, Sjors;
    • Mattsson-Carlgren, Niklas;
    • Veverova, Katerina;
    • Fowler, Christopher J.;
    • Boonkamp, Lynn;
    • Koel-Simmelink, Marleen;
    • Hussainali, Zulaiga;
    • Ruiters, Daimy N.;
    • Gaetani, Lorenzo;
    • Toja, Andrea
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11

    CSF synaptic biomarkers and cognitive impairment in multiple sclerosis.

    Published in:
    Journal of Neurology, 2025, v. 272, n. 1, p. 1, doi. 10.1007/s00415-024-12851-x
    By:
    • Barba, Lorenzo;
    • Gaetani, Lorenzo;
    • Sperandei, Silvia;
    • Di Sabatino, Elena;
    • Abu-Rumeileh, Samir;
    • Halbgebauer, Steffen;
    • Oeckl, Patrick;
    • Steinacker, Petra;
    • Parnetti, Lucilla;
    • Di FIlippo, Massimiliano;
    • Otto, Markus
    Publication type:
    Article
    12

    Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington's and Parkinson's disease.

    Published in:
    Journal of Neurology, 2022, v. 269, n. 9, p. 5136, doi. 10.1007/s00415-022-11187-8
    By:
    • Barschke, Peggy;
    • Abu-Rumeileh, Samir;
    • Al Shweiki, M. H. D. Rami;
    • Barba, Lorenzo;
    • Paolini Paoletti, Federico;
    • Oeckl, Patrick;
    • Steinacker, Petra;
    • Halbgebauer, Steffen;
    • Gaetani, Lorenzo;
    • Lewerenz, Jan;
    • Ludolph, Albert Christian;
    • Landwehrmeyer, Georg Bernhard;
    • Parnetti, Lucilla;
    • Otto, Markus
    Publication type:
    Article
    13

    Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German-Austrian retrospective multicenter study in patients with a clinically isolated syndrome.

    Published in:
    Journal of Neurology, 2016, v. 263, n. 12, p. 2499, doi. 10.1007/s00415-016-8302-1
    By:
    • Huss, André;
    • Halbgebauer, Steffen;
    • Öckl, Patrick;
    • Trebst, Corinna;
    • Spreer, Annette;
    • Borisow, Nadja;
    • Harrer, Andrea;
    • Brecht, Isabel;
    • Balint, Bettina;
    • Stich, Oliver;
    • Schlegel, Sabine;
    • Retzlaff, Nele;
    • Winkelmann, Alexander;
    • Roesler, Romy;
    • Lauda, Florian;
    • Yildiz, Özlem;
    • Voß, Elke;
    • Muche, Rainer;
    • Rauer, Sebastian;
    • Bergh, Florian
    Publication type:
    Article
    14
    15

    Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: a multicenter study.

    Published in:
    Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2021, v. 22, n. 3/4, p. 276, doi. 10.1080/21678421.2020.1861023
    By:
    • Steinacker, Petra;
    • Feneberg, Emily;
    • Halbgebauer, Steffen;
    • Witzel, Simon;
    • Verde, Federico;
    • Oeckl, Patrick;
    • Van Damme, Philip;
    • Gaur, Nayana;
    • Gray, Elizabeth;
    • Grosskreutz, Julian;
    • Jardel, Claude G.;
    • Kachanov, Mykyta;
    • Kuhle, Jens;
    • Lamari, Foudil;
    • Maceski, Aleksandra;
    • Del Mar Amador, Maria;
    • Mayer, Benjamin;
    • Morelli, Claudia;
    • Petri, Susanne;
    • Poesen, Koen
    Publication type:
    Article
    16
    17

    Prognostic serum biomarkers of synaptic, neuronal and glial injury in patients with acute ischemic stroke of the anterior circulation.

    Published in:
    European Journal of Neurology, 2025, v. 32, n. 1, p. 1, doi. 10.1111/ene.16581
    By:
    • Barba, Lorenzo;
    • Vollmuth, Christoph;
    • Halbgebauer, Steffen;
    • Ungethüm, Kathrin;
    • Hametner, Christian;
    • Essig, Fabian;
    • Kollikowski, Alexander M.;
    • Pham, Mirko;
    • Schuhmann, Michael K.;
    • Heuschmann, Peter U.;
    • Oeckl, Patrick;
    • Steinacker, Petra;
    • Romoli, Michele;
    • D'Anna, Lucio;
    • Abu‐Rumeileh, Samir;
    • Haeusler, Karl Georg;
    • Stoll, Guido;
    • Neugebauer, Hermann;
    • Otto, Markus
    Publication type:
    Article
    18
    19

    Serum β-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-47765-7
    By:
    • Barba, Lorenzo;
    • Vollmuth, Christoph;
    • Abu-Rumeileh, Samir;
    • Halbgebauer, Steffen;
    • Oeckl, Patrick;
    • Steinacker, Petra;
    • Kollikowski, Alexander M.;
    • Schultz, Cara;
    • Wolf, Judith;
    • Pham, Mirko;
    • Schuhmann, Michael K.;
    • Heuschmann, Peter U.;
    • Haeusler, Karl Georg;
    • Stoll, Guido;
    • Neugebauer, Hermann;
    • Otto, Markus
    Publication type:
    Article
    20

    Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials.

    Published in:
    Translational Neurodegeneration, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40035-021-00257-y
    By:
    • Witzel, Simon;
    • Frauhammer, Felix;
    • Steinacker, Petra;
    • Devos, David;
    • Pradat, Pierre-François;
    • Meininger, Vincent;
    • Halbgebauer, Steffen;
    • Oeckl, Patrick;
    • Schuster, Joachim;
    • Anders, Simon;
    • Dorst, Johannes;
    • Otto, Markus;
    • Ludolph, Albert C.
    Publication type:
    Article
    21

    Population‐Based Evidence for the Use of Serum Neurofilaments as Individual Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis.

    Published in:
    Annals of Neurology, 2024, v. 96, n. 6, p. 1040, doi. 10.1002/ana.27054
    By:
    • Witzel, Simon;
    • Huss, André;
    • Nagel, Gabriele;
    • Rosenbohm, Angela;
    • Rothenbacher, Dietrich;
    • Peter, Raphael S.;
    • Bäzner, Hansjörg;
    • Börtlein, Axel;
    • Dempewolf, Silke;
    • Schabet, Martin;
    • Hecht, Martin;
    • Kohler, Andreas;
    • Opherk, Christian;
    • Naegele, Andrea;
    • Sommer, Norbert;
    • Lindner, Alfred;
    • Alexudis, Christoforos;
    • Bachhuber, Franziska;
    • Halbgebauer, Steffen;
    • Brenner, David
    Publication type:
    Article
    22

    Serum Beta‐Synuclein Is Higher in Down Syndrome and Precedes Rise of pTau181.

    Published in:
    Annals of Neurology, 2022, v. 92, n. 1, p. 6, doi. 10.1002/ana.26360
    By:
    • Oeckl, Patrick;
    • Wagemann, Olivia;
    • Halbgebauer, Steffen;
    • Anderl‐Straub, Sarah;
    • Nuebling, Georg;
    • Prix, Catharina;
    • Loosli, Sandra V.;
    • Wlasich, Elisabeth;
    • Danek, Adrian;
    • Steinacker, Petra;
    • Ludolph, Albert C.;
    • Levin, Johannes;
    • Otto, Markus
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29

    Plasma pTau181 and biomarker combinations to identify Alzheimer´s disease at any stage along the AD continuum compared with both controls and non‐AD dementia.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077504
    By:
    • Doecke, James D;
    • Bellomo, Giovanni;
    • Vermunt, Lisa;
    • Alcolea, Daniel;
    • Halbgebauer, Steffen;
    • in 't Veld, Sjors G.J.G.;
    • Mattsson‐Carlgren, Niklas;
    • Veverova, Katerina;
    • Fowler, Christopher J;
    • Boonkamp, Lynn;
    • Koel‐Simmerlink, Marleen;
    • Hussainali, Zulaiga;
    • Ruiters, Daimy N.;
    • Gaetani, Lorenzo;
    • Toja, Andrea;
    • Fortea, Juan;
    • Pijnenburg, Yolande A.L.;
    • Lemstra, Afina W.;
    • van der Flier, Wiesje M.;
    • Hort, Jakub
    Publication type:
    Article
    30

    Plasma protein profiling reveals novel specific biomarkers reflecting the multifactorial nature of Alzheimer´s disease continuum.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074777
    By:
    • Bellomo, Giovanni;
    • in 't Veld, Sjors G.J.G.;
    • Doecke, James D;
    • Quesada, Carlos;
    • Vermunt, Lisa;
    • Alcolea, Daniel;
    • Halbgebauer, Steffen;
    • Mattsson‐Carlgren, Niklas;
    • Veverova, Katerina;
    • Boonkamp, Lynn;
    • Hok‐A‐Hin, Yanaika S.;
    • Fowler, Christopher J;
    • Fortea, Juan;
    • Gaetani, Lorenzo;
    • Toja, Andrea;
    • Pijnenburg, Yolande A.L.;
    • Lemstra, Afina W.;
    • van der Flier, Wiesje M.;
    • Hort, Jakub;
    • Otto, Markus
    Publication type:
    Article
    31
    32
    33

    High diagnostic performance of plasma and cerebrospinal fluid beta‐synuclein in the differential diagnosis of sporadic Creutzfeldt‐Jakob disease.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.071593
    By:
    • Rumeileh, Samir Abu;
    • Halbgebauer, Steffen;
    • Bentivenga, Giuseppe;
    • Barba, Lorenzo;
    • Baiardi, Simone;
    • Mastrangelo, Andrea;
    • Oeckl, Patrick;
    • Steinacker, Petra;
    • Mammana, Angela;
    • Capellari, Sabina;
    • Otto, Markus;
    • Parchi, Piero
    Publication type:
    Article
    34
    35

    Blood β‐synuclein is related to amyloid PET positivity in memory clinic patients.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 11, p. 4896, doi. 10.1002/alz.13046
    By:
    • Oeckl, Patrick;
    • Bluma, Marina;
    • Bucci, Marco;
    • Halbgebauer, Steffen;
    • Chiotis, Konstantinos;
    • Sandebring‐Matton, Anna;
    • Ashton, Nicholas J.;
    • Molfetta, Guglielmo Di;
    • Grötschel, Lana;
    • Kivipelto, Miia;
    • Blennow, Kaj;
    • Zetterberg, Henrik;
    • Savitcheva, Irina;
    • Nordberg, Agneta;
    • Otto, Markus
    Publication type:
    Article
    36
    37

    Relationship of serum beta‐synuclein with blood biomarkers and brain atrophy.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 4, p. 1358, doi. 10.1002/alz.12790
    By:
    • Oeckl, Patrick;
    • Anderl‐Straub, Sarah;
    • Danek, Adrian;
    • Diehl‐Schmid, Janine;
    • Fassbender, Klaus;
    • Fliessbach, Klaus;
    • Halbgebauer, Steffen;
    • Huppertz, Hans‐Jürgen;
    • Jahn, Holger;
    • Kassubek, Jan;
    • Kornhuber, Johannes;
    • Landwehrmeyer, Bernhard;
    • Lauer, Martin;
    • Prudlo, Johannes;
    • Schneider, Anja;
    • Schroeter, Matthias L.;
    • Steinacker, Petra;
    • Volk, Alexander E.;
    • Wagner, Matias;
    • Winkelmann, Juliane
    Publication type:
    Article
    38

    Quantitative mass spectrometry suggests beta‐synuclein as promising blood marker for synaptic degeneration in Alzheimer's disease: Biomarkers (non‐neuroimaging) / plasma/serum/urine biomarkers.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.040246
    By:
    • Oeckl, Patrick;
    • Halbgebauer, Steffen;
    • Straub, Sarah;
    • von Arnim, Christine;
    • Diehl‐Schmid, Janine;
    • Frölich, Lutz;
    • Grimmer, Timo;
    • Hausner, Lucrezia;
    • Denk, Johannes;
    • Jahn, Holger;
    • Weishaupt, Jochen H.;
    • Ludolph, Albert;
    • Otto, Markus
    Publication type:
    Article
    39
    40
    41

    Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer's disease.

    Published in:
    Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00451-8
    By:
    • Gómez de San José, Nerea;
    • Halbgebauer, Steffen;
    • Steinacker, Petra;
    • Anderl-Straub, Sarah;
    • Abu-Rumeileh, Samir;
    • Barba, Lorenzo;
    • Oeckl, Patrick;
    • Bellomo, Giovanni;
    • Gaetani, Lorenzo;
    • Toja, Andrea;
    • Mravinacová, Sára;
    • Bergström, Sofia;
    • Månberg, Anna;
    • Grassini, Alberto;
    • Rainero, Innocenzo;
    • Nilsson, Peter;
    • Parnetti, Lucilla;
    • Otto, Markus
    Publication type:
    Article